| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.35 | 4e-13 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.27 | 4e-09 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-08 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-08 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 6e-06 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.099 | 0.0004 |